Bimekizumab Efficacy and Safety Over 48 Weeks in US and Canadian Patients with Psoriasis who had a Treatment Interruption After 3 Years of Treatment: Results from BE RADIANT. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. s431, 2024. DOI: 10.25251/skin.8.supp.431. Disponível em: https://skin.dermsquared.com/skin/article/view/3043. Acesso em: 3 jul. 2025.